QP-Breast
AI-powered breast MRI interpretation for automated lesion detection and BI-RADS-compliant reporting.
Overview
QP-Breast® is an AI-based software tool designed to support radiologists in interpreting breast MRI scans and characterizing lesions. It targets radiology workflows where automated detection of suspicious breast cancer lesions can reduce diagnostic time and inter-reader variability, supporting more confident clinical decision-making.
The tool is intended for use in early detection and intervention of breast abnormalities. It is currently pending FDA 510(k) clearance and CE marking, and is not available for sale in the United States or Europe.
Core Capabilities
- Automated detection of suspicious breast cancer lesions in MRI images
- Lesion characterization to support differential diagnosis
- Reduction of inter-reader variability across radiology teams
- Acceleration of diagnostic turnaround time within radiology workflows
Planned and In-Development Features
- Modern breast MRI viewer with advanced imaging processing tools
- Semi-automated, structured reporting aligned with BI-RADS standards
- Surgical planning support functionality
- Neoadjuvant therapy response evaluation and prediction
- Additional AI-driven features aimed at supporting precision medicine in breast cancer
QP-Breast® is being developed with a roadmap toward a broader breast MRI platform. Its BI-RADS–compliant reporting and therapy response evaluation features reflect an orientation toward structured clinical workflows and oncology treatment planning.


